Joint Ventures: Lupus Health Inequalities, Growing Burden of ICI-Arthritis at EULAR 2026

June 26, 2026 10:56am 13 min

In this episode of Joint Ventures, host Rihards Buss, MD, consultant rheumatologist, Freeman Hospital, Newcastle, sits down with Sarah Dyball, MBBS, PhD, academic clinical lecturer, Centre for Musculoskeletal Research, U...

Joint Ventures: CAR-T, Early Diagnosis Reshape Scleroderma at EULAR 2026

June 23, 2026 7:49pm 13 min

The therapeutic framework for systemic sclerosis is undergoing a fundamental reorientation, moving away from managing visible fibrotic sequelae toward targeting the autoantibody-driven mechanisms believed to initiate and...

Joint Ventures: Aiming for Targeted First-Line Therapy in Early RA at EULAR 2026

June 23, 2026 7:41pm 7 min

In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, academic clinical lecturer in rheumatology, University of Leeds, was joined at the European Alliance of Associations for Rheumatology (EULAR) 2026 annual c...

Joint Ventures: EULAR 2026 Congress Preview

May 29, 2026 11:33am 42 min

In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle,...

Joint Ventures: The B-Cell Story, Part 2 — Ianalumab and the Next Chapter in Sjögren's and Lupus

May 28, 2026 2:22pm 36 min

In the second part of this Joint Ventures episode on B cell therapies in rheumatic disease, hosts Jack Arnold, MBBS, PhD, and Rihards Buss, MD, return with guest Lucy Carter, MBBS, PhD, to move beyond the question of how...

Joint Ventures: The B-Cell Story, Part 1 — From Rituximab to the Next Frontier

May 28, 2026 2:04pm 29 min

In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle,...

Joint Ventures: GLP-1 Receptor Agonists — From Metabolic Drug to Immunomodulator? Part 2

May 28, 2026 2:03pm 27 min

In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle,...

Joint Ventures: GLP-1 Receptor Agonists — From Metabolic Drug to Immunomodulator? Part 1

May 28, 2026 2:02pm 28 min

In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle,...

Joint Ventures: Nipocalimab Advances and a Deucravacitinib Decision Looms

May 28, 2026 2:01pm 25 min

In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MBBS, a consultant rheumatologist at Freeman Hospital, dive int...

Introducing Joint Ventures, With Jack Arnold, MBBS, PhD, and Rihards Buss, MBBS

May 28, 2026 2:00pm 22 min

Introducing Joint Ventures — a new podcast exploring advances in rheumatologic disease and what they mean for real-world practice. Hosted by RheumatologyLive, the series is led by Jack Arnold, MBBS, PhD, and Rihards Buss...

Closing the Gap Between IBD Therapies and Patient Outcomes, With David Rubin, MD

May 06, 2026 4:06pm 11 min

Despite more than 14 approved therapies for Crohn's disease and ulcerative colitis, many patients still aren't reaching remission. At DDW 2026, David Rubin, MD, of the University of Chicago Medicine explains why the prob...

FSGS Drug Development No Longer a ‘Graveyard’: What Comes After Sparsentan’s Approval

April 19, 2026 1:09pm 13 min

Liver Lineup: Closing the Gap in Women’s Liver Health

April 16, 2026 3:40pm 44 min

In this episode of Liver Lineup, hosts Nancy Reau, MD, and Kimberly Brown, MD, are joined by Meena Bansal, MD, to examine how liver disease uniquely affects women across the lifespan. While conditions like metabolic dysf...

Liver Lineup: Navigating Genetic Testing in Cholestatic Liver Disease

April 07, 2026 3:00pm 56 min

In this episode of Liver Lineup, hosts Nancy Reau, MD, and Kimberly Brown, MD, are joined by Saul Karpen, MD, PhD, and Robert Gish, MD, for a practical, clinician-focused discussion on the evolving role of genetic testin...

HCPLive 5 Stories in Under 5: Week of 03/08

March 15, 2026 6:02pm 4 min

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impactin...

HCPLive 5 Stories in Under 5: Week of 02/15

February 23, 2026 6:05pm 5 min

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impactin...

ICD-10 Adoption and the True Burden of Short Bowel Syndrome With Alan Buchman, MD, MSPH

February 18, 2026 10:00am 7 min

Accurately defining the population of patients with short bowel syndrome (SBS) and intestinal failure has long been a challenge in gastroenterology. In an effort to bring greater clarity to the field, Alan Buchman MD, MS...

When Platelet Increments Matter, With Ruchika Goel, MD

February 12, 2026 6:00pm 7 min

HCPLive 5 Stories in Under 5: Week of 02/01

February 08, 2026 9:20pm 5 min

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impactin...

Liver Lineup: Managing MASLD and MASH Amid Limited Awareness, Overlapping Risk Factors

February 04, 2026 9:16am 29 min

In this episode of Liver Lineup: Updates and Unfiltered Insights, Nancy Reau, MD, and Kimberly Brown, MD, turn their attention to metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction...